Pemetrexed approved for the fi rst-line treatment of non-small-cell lung cancer: summary of the NICE appraisal. The lancet oncology [Lancet Oncol] Journal article

Title	Pemetrexed approved for the fi rst-line treatment of non-small-cell lung cancer: summary of the NICE appraisal.
Author(s)	Vrouchou P, Kandaswamy P, George E, Barnett D
Source	Lancet Oncol 2009 Nov; 10(11):1031-2.
Language	eng
Pub Type(s)	News
PubMed ID	19891055

Advertise on this site.